Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, December 04, 2019
AWS has announced a multi-year strategic collaboration with Novartis to develop the pharmaceutical company’s core pharmaceutical manufacturing, supply chain, and delivery operations using AWS’s portfolio of cloud services.
read more
Avrio Biopharmaceuticals, LLC, a leading global cGMP contract aseptic manufacturing organization, announced the appointment of Laura Jones, Ph.D., J.D., M.S., M.B.A., as Vice President of Quality and Regulatory Affairs. Dr. Jones will be responsible ...
read more
Avondale Pharmaceuticals announced an exclusive, product development partnership with Oxford Pharmaceuticals, a pharmaceutical manufacturer and distributor based in Birmingham, AL.
read more
Avomeen Analytical Services has hired Khanh Ngo Courtney as its Biological Chemistry Project Director. Through this newly created position, Courtney will help grow Avomeen’s large-molecule and protein therapeutics business segment by partnering with ...
read more
Wednesday, December 23, 2020
AvKARE is voluntarily recalling one lot of Sildenafil 100 mg tablets and one lot of Trazodone 100mg tablets to the consumer level.
read more
Avixgen, a subsidiary of Dx&Vx, has signed a licensing-out agreement worth approximately $360M with a U.S. biotechnology company for its next-generation drug delivery platform, ACP (Advanced Cell Penetrating Peptide). Avixgen is a drug development ...
read more
Thursday, August 14, 2025
Avista Therapeutics and Forge Biologics announced a strategic partnership to advance the development and manufacturing of AVST-101, Avista’s lead gene therapy candidate targeting X-linked retinoschisis (XLRS), a serious inherited retinal disease.
read more
Tuesday, February 09, 2016
Avista Pharma Solutions has appointed Eric Setzer as Chief Financial Officer (CFO). Mr. Setzer is a finance and operations executive with over twenty years of experience in various roles within growing technology and life science companies.
read more
Avista Pharma Solutions, Inc has announced that the $4 million expansion of its 26,000-square foot contract testing facility in Agawam, Massachusetts is now complete. For over 30 years, the Agawam site has provided superior service to pharmaceutical ...
read more
Monday, November 13, 2017
Avista Pharma Solutions has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, Colorado site.
read more
Wednesday, August 30, 2017
Avista Pharma Solutions announced Eric Evans has been named its Chief Financial Officer effective August 28, 2017.
read more
Avista Pharma Solutions, Inc. has initiated a significant expansion and enhancement of its contract testing facility in Agawam, Mass.
read more
Thursday, September 08, 2016
Avista Pharma Solutions has announced the sale of its facility in Eagan, Minn. to Microbiology Research Associates, a portfolio company of Thompson Street Capital Partners.
read more
Avista Pharma Solutions has completed the acquisition of Solid Form Solutions located in Edinburgh, Scotland.
read more
Avista Healthcare Partners and Damier Group have signed a definitive agreement to acquire sanotact Group GmbH, an established and innovative German vitamins, minerals, and supplements ("VMS") platform.
read more